Silence is STILL Golden

April 23rd, 2007

Business Objects to buy Cartesis. The consolidation in BI Vendors continues and I will keep my silence on where I think it is going, for now.  Look for my thoughts in an upcoming BI Review article (my first co-authored article, also).

Thoughts on PMI MetSig Webinar

April 23rd, 2007

I just completed my webinar for PMI Metrics Special Interest Group as part of their Congress 2007 month-long event and have received  fair amount of feedback.

If you did not attend, I did an overview of the CPO Book and the major themes including analysis chains and based on the feedback, I think I need to do this more often.  Many of my webinars and sessions have become more focused, particularly on my latest soapbox of CPM-MDM coming together, but the need for executive level metrics, which is the them of my book, still needs to be talked about.

Some of the feedback was very focused on how to ’sell’ metrics internally or get buy in at the right level.  Learning from history, the best way is repetition in multiple channels.   So, if you are reading this and need help selling the concept of CPO and/or Metrics based decision making internally, reach out to me directly and let me know how to help.  Or if you have promoted well internally, let me know what worked.

Physician Spend

April 16th, 2007

Here is the online link to the Physician Spend article. Even if you do not deal in any way with the life sciences, there are serious lessons to be learned from anyone who has a customer. For life sciences the physician is a key customer and using data management for the better understanding (and in this case compliance also) is key to success. Although not as simple as replace physician with customer in this article, the lessons can be universal to CRM.

DM Review April Issue Link

Compliance. It’s not just for afterthoughts.

April 3rd, 2007

In the April issue of  DM Review, I discussed the concept of Going Beyond Compliance.  Basically, there are many projects, in this case I use Physician Spend for Pharma, that are compliance driven.  Two things I learned from the SOX stampede of a few years ago:

  1. It is a heck of a lot easier to get a project in front of executive management for funding when it is compliance driven.
  2. If you only fix the compliance problem, the solution will need to be revisited for other business reasons shortly after.

Thus, when you are doing a compliance driven project, try to satisfy some other business challenges or constituencies.  The gentle balancing act is adding the effort to go beyond compliance without breaking the budget bank!